China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 September 2016, Volume 26 Issue 9 Previous Issue Next Issue

The preliminary report about the efficacy and safety evaluation of apatinib in progressive radioactive iodine-refractory differentiated thyroid cancer within 8 weeks

LIN Yansong, WANG Chen, LI Hui, et al

2016, 26 (9): 721-726. doi: 10.19401/j.cnki.1007-3639.2016.09.001

Abstract ( 455) PDF (1771KB) ( 1656 )

Long-term survival trends of bladder cancer from 1972 to 2011 in Qidong

CHEN Yongsheng, CHEN Jianguo, ZHU Jian, et al

2016, 26 (9): 727-734. doi: 10.19401/j.cnki.1007-3639.2016.09.002

Abstract ( 379) PDF (785KB) ( 1216 )

The expression of NCX1 and its effect on proliferation and migration of hepatocellular carcinoma cells through regulation of intracellular Ca²⁺

XU Jingyu, JIANG Yixia, XIE Rui, et al

2016, 26 (9): 735-742. doi: 10.19401/j.cnki.1007-3639.2016.09.003

Abstract ( 327) PDF (2862KB) ( 1477 )

miR-222 promotes retinoblastoma cell proliferation and invasion by targeting RB1

LIU Yuefeng, ZHANG Yong, ZHONG Xiaodong, et al

2016, 26 (9): 743-749. doi: 10.19401/j.cnki.1007-3639.2016.09.004

Abstract ( 406) PDF (4900KB) ( 1280 )

BRD4 scilencing plus gemcitabine may be a novel therapy for triple-negative breast cancer

CHEN Yuli, ZHU Qinwei, SUI Xiaomei, et al

2016, 26 (9): 750-755. doi: 10.19401/j.cnki.1007-3639.2016.09.005

Abstract ( 323) PDF (2861KB) ( 1336 )

The influence of different concentrations of IL-2 on the cultivation system for peptide-specific CTL induction in vitro

LI Anqi, QI Yuanming, ZHOU Zhejun, et al

2016, 26 (9): 756-762. doi: 10.3969/j.issn.1007-3969.2016.09.006

Abstract ( 546) PDF (1219KB) ( 3067 )

Effect of RNAi targeting BMI-1 gene on radiosensitivity of esophageal carcinoma cells

YANG Xingxiao, LI Youmei, SONG Heng, et al

2016, 26 (9): 763-769. doi: 10.3969/j.issn.1007-3969.2016.09.007

Abstract ( 602) PDF (1435KB) ( 1644 )

Radiation dosimetry estimates of ¹⁸F-fluoroestradiol based on whole-body PET imaging of mice

ZHANG Jianping, HE Simin, GU Bingxin, et al

2016, 26 (9): 770-776. doi: 10.19401/j.cnki.1007-3639.2016.09.008

Abstract ( 574) PDF (1809KB) ( 2206 )

A retrospective study of 500 mg fulvestrant in recurrent or metastatic breast cancer patients pretreated with the third generation of aromatase inhibitors

ZHAO Yannan, GONG Chengcheng, HU Xichun, et al

2016, 26 (9): 777-783. doi: 10.19401/j.cnki.1007-3639.2016.09.009

Abstract ( 566) PDF (1148KB) ( 1666 )

Experimental study on forskolin combined with bortezomib inducing apoptosis in bortezomibresistant multiple myeloma cells

WANG Yingying, ZHONG Yao, YU Yehua, et al

2016, 26 (9): 784-789. doi: 10.19401/j.cnki.1007-3639.2016.09.010

Abstract ( 495) PDF (1174KB) ( 1297 )

Clinical and CT imaging features of primary thyroid lymphoma

CHEN Hong, ZHOU Zhengrong

2016, 26 (9): 790-794. doi: 10.19401/j.cnki.1007-3639.2016.09.011

Abstract ( 350) PDF (2267KB) ( 1471 )

Advances in the study of aspirin in colorectal cancer prevention and treatment and related mechanisms

TONG Duo, ZHANG Wen

2016, 26 (9): 795-800. doi: 10.19401/j.cnki.1007-3639.2016.09.012

Abstract ( 384) PDF (761KB) ( 1699 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat